Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells

Sphingosine kinase 2 (Sphk2) has an oncogenic role in cancer. A recently developed first-in-class Sphk2 specific inhibitor ABC294640 displays antitumor activity in many cancer models. However, the role of Sphk2 and the antitumor activity of its inhibitor ABC294640 are not known in cholangiocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xiwei, Chaiteerakij, Roongruedee, Moser, Catherine D., Shaleh, Hassan, Boakye, Jeffrey, Chen, Gang, Ndzengue, Albert, Li, Ying, Zhou, Yanling, Huang, Shengbing, Sinicrope, Frank A., Zou, Xiaoping, Thomas, Melanie B., Smith, Charles D., Roberts, Lewis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991440/
https://www.ncbi.nlm.nih.gov/pubmed/26956050
http://dx.doi.org/10.18632/oncotarget.7914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991440/
https://www.ncbi.nlm.nih.gov/pubmed/26956050
http://dx.doi.org/10.18632/oncotarget.7914

Ejemplares similares